Israel vs Lithuania: The number of people with susceptibility test result for rifampicin
Israel
100
in 2021
Lithuania
100
in 2021
Israel rank
2nd
Lithuania rank
2nd
The number of people with susceptibility test result for rifampicin over time
- Israel
- Lithuania
How they compare
Israel currently reports 100 against 100 in Lithuania, a difference of 0.
Across all 5 years both countries report, Lithuania has been ahead every year.
Israel ranks 2nd and Lithuania ranks 2nd of 146 countries.
Lithuania has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Israel | Lithuania | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 98.2 | 100 | 1.8 | Lithuania |
| 2020s | 100 | 100 | 0 | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Israel or Lithuania?
- Israel, at 100 against 100 in Lithuania as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Israel and Lithuania?
- 0, with Israel ahead.
- How many years of comparable data are there for Israel and Lithuania?
- 5 years are reported by both, from 2017 to 2021.
- How do Israel and Lithuania rank globally for the number of people with susceptibility test result for rifampicin?
- Israel ranks 2nd and Lithuania ranks 2nd of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.